范围内的点及其他血糖指标在2型糖尿病肾病中的研究进展  

Research progress of point in range and other blood glucose management indicators in type 2 diabetic nephropathy

作　　者：侯丹丹 李雅欣 武慧敏 何继瑞[1] HOU Dandan;LI Yaxin;WU Huimin;HE Jirui(Special Needs Department of Internal Medicine,Second Hospital of Lanzhou University,Lanzhou,Gansu,730030)

机构地区：[1]兰州大学第二医院特需内科,甘肃兰州730030

出　　处：《实用临床医药杂志》2022年第13期145-148,共4页Journal of Clinical Medicine in Practice

摘　　要：与未合并微血管并发症的糖尿病患者比较,糖尿病肾病患者通常病程长、血糖波动幅度大,易合并多种不良结局。临床中持续血糖监测(CGM)系统尚未被常规使用,目前自我血糖监测(SMBG)仍然是监测血糖并指导治疗的重要工具。SMBG提供的时点血糖不是随时间变化的连续血糖水平,因此与葡萄糖目标范围内时间(TIR)比较,范围内的点(PIR)提供的数据较少。但PIR是血糖控制的有效指标,与CGM评估的TIR效果相当,可作为评估血糖波动的有效指标。本文对PIR代替TIR作为新的血糖监测指标在2型糖尿病肾病中的应用进行综述。Compared with diabetic patients without microvascular complications,patients with diabetic nephropathy usually have a longer course of disease,larger fluctuations in blood glucose,and are more likely to have multiple adverse outcomes.Continuous glucose monitoring(CGM)systems have not been routinely used in clinical practice,thus self-monitoring of blood glucose(SMBG)is still an important tool for monitoring blood glucose and guiding treatment.SMBG provides point blood glucose,not a continuous trend over time,so point in range(PIR)provides less data than time in target range(TIR).However,some studies have found that PIR is an effective marker of blood sugar control,which is comparable to TIR assessed by CGM,and can be used as an effective indicator for evaluating blood sugar fluctuations.This article reviewed the application of PIR instead of TIR as a new blood glucose monitoring index in type 2 diabetic nephropathy.

关 键 词：范围内的点 自我血糖监测 持续血糖监测 糖尿病肾病 目标范围内时间 2型糖尿病 

分 类 号：R587.1[医药卫生—内分泌] R816.6[医药卫生—内科学]